Gerd Assmann
Impact in
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 0.02%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
Papers in
- Surgery 189
- Lipoproteins and Cardiovascular Health 123
- Cholesterol and Lipid Metabolism 72
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 143
- Co-authors
- H. Schulte (90 shared papers)Arnold von Eckardstein (107 shared papers)Paul Cullen (50 shared papers)Jerzy–Roch Nofer (42 shared papers)Harald Funke (85 shared papers)Udo Seedorf (48 shared papers)Gerd Schmitz (22 shared papers)Yadong Huang (12 shared papers)
- Journals
- Atherosclerosis (23 papers)Journal of Lipid Research (21 papers)Arteriosclerosis Thrombosis and Vascular Biology (21 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (19 papers)Journal of Biological Chemistry (19 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Gerd Assmann
453 papers receiving 24.8k citations
Gerd Assmann's Hit Papers
Peers
Comparison fields: 5 of 161
- Endocrinology, Diabetes and Metabolism 7.9k
- Surgery 10.4k
- Cancer Research 3.2k
- Cardiology and Cardiovascular Medicine 3.7k
- Biochemistry 1.3k
Countries citing papers authored by Gerd Assmann
This map shows the geographic impact of Gerd Assmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Assmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Assmann more than expected).
Fields of papers citing papers by Gerd Assmann
This network shows the impact of papers produced by Gerd Assmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Assmann. The network helps show where Gerd Assmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerd Assmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 455 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 Hit paper breakdown → | 1999 | 1191 |
| 2 | Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Munster (PROCAM) Study Hit paper breakdown → | 2002 | 1093 |
| 3 | High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport Hit paper breakdown → | 1996 | 572 |
| 4 | High Density Lipoproteins and Arteriosclerosis Hit paper breakdown → | 2001 | 561 |
| 5 | HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3 Hit paper breakdown → | 2004 | 539 |
| 6 | HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3 Hit paper breakdown → | 2004 | 511 |
| 7 | HDL Cholesterol and Protective Factors in Atherosclerosis Hit paper breakdown → | 2004 | 502 |
| 8 | 2002 | 474 | |
| 9 | Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Hit paper breakdown → | 1994 | 456 |
| 10 | 1996 | 377 | |
| 11 | 1990 | 360 | |
| 12 | 1983 | 349 | |
| 13 | 1988 | 316 | |
| 14 | 2001 | 302 | |
| 15 | 1983 | 287 | |
| 16 | 2003 | 284 | |
| 17 | 1997 | 278 | |
| 18 | 1999 | 262 | |
| 19 | The Münster Heart Study (PROCAM). Results of follow-up at 8 years. | 1998 | 253 |
| 20 | 1975 | 237 |
About Gerd Assmann
Gerd Assmann is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 455 papers that have together received 26.0k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (143 papers), Lipoproteins and Cardiovascular Health (123 papers), Cholesterol and Lipid Metabolism (72 papers), Cancer, Lipids, and Metabolism (58 papers), Peroxisome Proliferator-Activated Receptors (37 papers), Lipid metabolism and disorders (32 papers), Blood properties and coagulation (30 papers) and Sphingolipid Metabolism and Signaling (25 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.9k citations), Surgery (10.4k citations), Cancer Research (3.2k citations), Cardiology and Cardiovascular Medicine (3.7k citations) and Biochemistry (1.3k citations). Gerd Assmann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include H. Schulte, Arnold von Eckardstein, Paul Cullen, Jerzy–Roch Nofer, Harald Funke, Udo Seedorf, Gerd Schmitz, Yadong Huang, Manfred Fobker and Stephan Rust. Their work appears in journals such as Atherosclerosis, Journal of Lipid Research, Arteriosclerosis Thrombosis and Vascular Biology, Clinical Chemistry and Laboratory Medicine (CCLM) and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.